CLINICAL TRIAL: The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection.
Between this, Chloraquine, and Avigan, among several others, it looks like there may be some useful treatments forthcoming.